ICLR
ICON Public Limited Company · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables):
amplitud de titulares -5.3% ·
flujo de acciones -17.8% ·
nuevas posiciones netas -11.1%
· fórmula
Distribución amplia: acciones en descenso y menos titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 111 | +2 | 54.20M | $9.33B | +10 | −9 |
| Q1 2026 | 112 | -7 | 49.87M | $5.61B | +7 | −15 |
| Q4 2025 | 119 | -2 | 53.17M | $9.70B | +2 | −3 |
| Q3 2025 | 18 | -1 | 14.11M | $2.47B | +2 | −4 |
| Q2 2025 | 17 | +3 | 17.03M | $2.48B | +3 | n/a |
| Q1 2025 | 11 | -1 | 10.01M | $1.75B | +1 | −2 |
| Q4 2024 | 12 | -1 | 9.48M | $1.99B | +2 | −3 |
| Q3 2024 | 12 | -1 | 9.43M | $2.71B | +1 | −2 |
| Q2 2024 | 13 | n/a | 9.47M | $2.97B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 4.64M | +26.6% | $811.50M | 0.1% | ▲ Add | 6 | SEC ↗ ×9 |
| 2 | Harris Associates (Oakmark) ✦ | 2.34M | +43.0% | $409.95M | 0.7% | ▲ Add | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 1.93M | -1.6% | $338.32M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 4 | D. E. Shaw & Co. ✦ | 1.48M | -39.3% | $258.49M | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 5 | Morgan Stanley ✦ | 500.38K | n/a | $87.57M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 6 | Point72 Asset Management ✦ | 462.05K | -13.8% | $80.86M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 7 | Goldman Sachs Group ✦ | 448.77K | n/a | $78.53M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 8 | Glenview Capital ✦ | 371.42K | Nuevo | $65.00M | 1.6% | New | 1 | SEC ↗ |
| 9 | State Street Global Advisors ✦ (pasivo) | 358.92K | -14.1% | $62.81M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | JPMorgan Chase ✦ | 277.74K | n/a | $48.60M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 11 | Citadel Advisors ✦ | 269.98K | -86.1% | $47.25M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 12 | BlackRock ✦ (pasivo) | 254.06K | -22.2% | $44.46M | 0.0% | ▼ Trim | 2 | SEC ↗ ×10 |
| 13 | Capital World Investors ✦ | 228.38K | Nuevo | $39.97M | 0.0% | New | 1 | SEC ↗ |
| 14 | Millennium Management ✦ | 222.18K | -64.0% | $38.88M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 117.33K | -90.1% | $20.53M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | Geode Capital Management ✦ (pasivo) | 93.72K | +11.1% | $16.40M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | The Vanguard Group ✦ (pasivo) | 88.56K | -60.6% | $15.50M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 18 | Two Sigma Investments ✦ | 28.96K | -78.2% | $5.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Glenview Capital | $65.00M | 1.6% |
| Capital World Investors | $39.97M | 0.0% |
Posición cerrada
| Norges Bank | $158.64M | era 0.0% |
| Baupost Group | $58.91M | era 1.4% |
| Renaissance Technologies | $47.25M | era 0.1% |
| Adage Capital Partners | $5.27M | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 414 tenedores, 78.10M acciones, $8.66B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 3.25K acc. · $569,625
Director · 5.00K acc. · $875,875
Director · 5.00K acc. · $875,875
Officer · 259 acc. · $42,416
Officer · 1.59K acc. · $261,672
Officer · 180 acc. · $29,792
Director · 87 acc. · $14,157
Director · 97 acc. · $15,886
Director · 590 acc. · $97,037
Director · 67 acc. · $11,089
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología